Skip to main content
TipRanks
Go Ultimate75% OFF

Ultragenyx Pharmaceutical (RARE) Q1 2023 Earnings Report

1 Followers

MX:RARE Q1 2023 EPS Results

Actual EPS
-MXN 43.14
Consensus EPS
-MXN 36.88
Beat/Miss
Missed by -MXN 6.26
One Year Ago EPS
-MXN 40.55

MX:RARE Q1 2023 Revenue Results

Actual Revenue
MXN 1.86B
Expected Revenue
MXN 1.94B
Beat/Miss
Missed by -MXN 78.12M
YoY Revenue Growth
+25.72%

Earnings Announcement Details

Quarter
Q1 2023
Date
05/04/2023
Time
After Close
Conference Call
Thursday, May 4, 2023
MX:RARE Upcoming Earnings

Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.

Q1 2023 Earnings Call Audio

MX:RARE Q1 2023 Earnings Call
0:00 / 0:00

Q1 2023 Earnings Slide Deck

Q1 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:RARE Earnings History

MX:RARE earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 18, 20272026 (Q4)43.83--23.88――
Nov 03, 20262026 (Q3)-20.37-21.48-33.5135.91% (+12.03)
Aug 04, 20262026 (Q2)-23.00-16.66-21.6623.08% (+5.00)
May 05, 20262026 (Q1)-27.55-34.07-29.07-17.20% (-5.00)
Feb 12, 20262025 (Q4)-20.24-23.88-25.747.19% (+1.85)
Nov 04, 20252025 (Q3)-22.85-33.51-25.92-29.29% (-7.59)
Aug 05, 20252025 (Q2)-24.01-21.66-28.1423.03% (+6.48)
May 06, 20252025 (Q1)-29.59-29.07-37.5922.66% (+8.52)
Feb 13, 20252024 (Q4)-24.22-25.74-28.148.55% (+2.41)
Nov 05, 20242024 (Q3)-27.48-25.92-41.2937.22% (+15.37)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed